Table 3

Prevalence and DALYs for RA in the age range 5–100 years, by region and sex, GBD 2010 Study

		Age-standardised			All ages—thousands
Region	Sex	Prevalence %	LCL %	UCL %	DALYs	LCL	UCL
Global	Male	0.13	0.12	0.13	1201	927	1538
	Female	0.35	0.34	0.37	3618	2721	4602
Asia, central	Male	0.16	0.12	0.21	17	12	23
	Female	0.39	0.30	0.53	47	32	65
Asia, east	Male	0.08	0.08	0.09	222	167	297
	Female	0.24	0.22	0.27	601	446	779
Asia Pacific, high income	Male	0.22	0.18	0.26	62	45	84
	Female	0.57	0.48	0.69	229	162	307
Asia, south	Male	0.08	0.07	0.09	212	130	291
	Female	0.26	0.24	0.29	445	317	583
Asia, southeast	Male	0.08	0.07	0.09	68	51	87
	Female	0.23	0.21	0.26	186	136	242
Australasia	Male	0.26	0.15	0.46	9	5	16
	Female	0.66	0.37	1.11	31	18	53
Caribbean	Male	0.15	0.12	0.18	7	5	9
	Female	0.39	0.32	0.49	24	17	33
Europe, central	Male	0.15	0.11	0.19	24	16	33
	Female	0.41	0.31	0.52	95	63	133
Europe, eastern	Male	0.14	0.08	0.22	43	28	64
	Female	0.38	0.24	0.57	177	113	265
Europe, western	Male	0.24	0.21	0.28	148	107	197
	Female	0.63	0.55	0.75	548	382	734
Latin America, Andean	Male	0.15	0.10	0.22	8	5	12
	Female	0.39	0.25	0.59	27	18	42
Latin America, central	Male	0.14	0.12	0.17	38	28	52
	Female	0.40	0.34	0.49	138	101	180
Latin America, southern	Male	0.20	0.13	0.30	14	9	21
	Female	0.51	0.33	0.78	51	31	83
Latin America, tropical	Male	0.14	0.13	0.15	27	20	36
	Female	0.38	0.35	0.41	105	76	135
North Africa Middle East	Male	0.09	0.08	0.11	42	30	55
	Female	0.24	0.20	0.28	121	86	163
North America, high income	Male	0.24	0.22	0.27	107	78	141
	Female	0.63	0.58	0.70	388	285	503
Oceania	Male	0.09	0.05	0.14	0.9	0.6	1
	Female	0.25	0.15	0.41	2	1	4
Sub-Saharan Africa, central	Male	0.12	0.07	0.18	12	6	22
	Female	0.30	0.19	0.47	30	17	50
Sub-Saharan Africa, east	Male	0.11	0.08	0.14	92	46	209
	Female	0.29	0.23	0.37	232	152	433
Sub-Saharan Africa, south	Male	0.10	0.09	0.12	9	7	12
	Female	0.30	0.26	0.34	28	21	36
Sub-Saharan Africa, west	Male	0.10	0.09	0.12	38	24	67
	Female	0.28	0.25	0.32	112	81	164

DALYs, disability-adjusted life years; GBD, Global Burden of Disease; RA, rheumatoid arthritis; LCL, lower confidence limit; UCL, upper confidence limit.